Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,046 | 7,290 | 10,789 | 9,127 | 16,122 |
| Receivables | 249 | 437 | 308 | 344 | 397 |
| Other current assets | 222 | 194 | 168 | 85 | 83 |
| TOTAL | $7,473 | $8,204 | $12,111 | $11,336 | $18,585 |
| Non-Current Assets | |||||
| PPE Net | 40 | 43 | 50 | 56 | 67 |
| Other Non-Current Assets | 371 | 432 | 510 | 395 | 496 |
| TOTAL | $410 | $475 | $560 | $451 | $562 |
| Total Assets | $7,883 | $8,679 | $12,671 | $11,787 | $19,147 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,203 | 3,140 | 3,978 | 4,198 | 3,986 |
| TOTAL | $3,444 | $3,439 | $4,274 | $4,449 | $4,302 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 39 | 91 | 167 | 231 | 816 |
| TOTAL | $39 | $91 | $167 | $231 | $816 |
| Total Liabilities | $3,483 | $3,531 | $4,440 | $4,681 | $5,118 |
| Shareholders' Equity | |||||
| Common Shares | 1,247 | 1,209 | 676 | 67,597 | 70,684 |
| Retained earnings | -380,697 | -366,620 | -358,362 | -354,282 | -362,643 |
| Other shareholders' equity | 98,362 | 95,139 | 94,764 | 28,975 | 28,724 |
| TOTAL | $4,400 | $5,148 | $8,231 | $7,107 | $14,029 |
| Total Liabilities And Equity | $7,883 | $8,679 | $12,671 | $11,787 | $19,147 |